Navigation Links
Head-to-Head 96-Week Study Shows EPZICOM(R) is Comparable to Truvada(R) in Efficacy and Safety Measures in HIV Treatment-Naive Patients
Date:8/7/2008

tions are not known at this time.

The most common side effects seen with the drugs in EPZICOM dosed once-daily were allergic reaction, trouble sleeping, depression, headache, tiredness, dizziness, nausea, diarrhea, rash, fever, stomach pain, abnormal dreams, and anxiety. Most of the side effects do not cause people to stop taking EPZICOM.

For additional important information about EPZICOM please visit http://www.epzicom.com.

About GlaxoSmithKline

GlaxoSmithKline is one of the world's leading research-based pharmaceutical and healthcare companies and an industry leader in HIV research and therapies. The company is engaged in basic research programs designed to investigate new targets to treat HIV. For full information on GSK's HIV medications, please visit http://www.treatHIV.com.

Cautionary statement regarding forward-looking statements

Under the safe harbor provisions of the U.S. Private Securities Litigation Reform Act of 1995, GSK cautions investors that any forward-looking statements or projections made by GSK, including those made in this announcement, are subject to risks and uncertainties that may cause actual results to differ materially from those projected. Factors that may affect GSK' s operations are described under 'Risk Factors' in the 'Business Review' in the company' s Annual Report on Form 20-F for 2007.

Enquiries:

US Media enquiries: Marc Meachem (919) 483 2839

Mary Anne Rhyne (919) 483 2839

US Analyst/ Investor enquiries: Frank Murdolo (215) 751 7002

Tom Curry (215) 751 5419


'/>"/>
SOURCE GlaxoSmithKline
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3 4 5

Related medicine news :

1. In Landmark Phase III Head-to-Head Study, Prasugrel Statistically Superior to Clopidogrel in Reducing Risk of Heart Attack
2. Daiichi Sankyo, Lilly Announce New Prasugrel Head-to-Head Phase III Study Against Clopidogrel
3. Once-Weekly Exenatide Showed Statistical Superiority in Glucose Control Compared to BYETTA in Head-to-Head Study
4. Study sees need for standardized evaluation of antibody response to HIV-1
5. Study Links Agent Orange to Prostate Cancer in Vietnam Vets
6. KLRI Receives Grant From NIH to Study Stress Resilience in Older Adults
7. Alcohol consumption declining, according to results of new study
8. UNC study: shape, not just size, impacts effectiveness of emerging nanomedicine therapies
9. Study: verbal aggression may affect childrens behavior
10. Fudan-Cinpathogen Study Shows Chronic Lymphoid Neoplasms are More Common in Shanghai Than Thought
11. First national study of diving-related injuries

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/9/2009)...nds to move lab findings into human therapy for di... nerve damage ,, ANN ARBOR, Mich., Nov. 9 /PRN...ity of Michigan Department of Neurology have recei...y for neuropathic pain, a difficult-to-treat condi...damage to nerve without obvious tissue injury. ,...
(Date:11/9/2009)...struction industry, respiratory disease, often lea... is a major public health concern. Studies led by...ia Tech,s School of Construction, have shown that ...ve in reducing the dust that causes these health h...technology remains very low. , To find out why, ...
(Date:11/9/2009)...as might be the reason why African Americans are n...me rate as similar patients in other racial groups...reas transplantation at Georgetown University Hosp...own University Medical Center, and colleagues expl...American Journal of Transplantation . , Medicar...
(Date:11/9/2009)...ership to bring next generation of sports medicine... Colorado Springs, CO and Marin...ted States Olympic Committee (USOC) and D.I.S.C. S...a strategic partnership in which D.I.S.C. will bec...the 2012 Olympic Games. With this agreement D.I.S....
(Date:11/9/2009)...uver Career College launches month-long clothing d...y, BC (Vocus) November 9, 2009 -- The students and...igging through their closets to find clothing to. ... same in order to help women and children in need....community here on campus amongst our students, sta...
Breaking Medicine News(10 mins):Health News:U-M Researchers Receive $1.8 Million Grant to Develop New Therapy for Neuropathic Pain 2Health News:Dust control research leads to a NIOSH grant to facilitate adoption of hazard controls 2Health News:Dust control research leads to a NIOSH grant to facilitate adoption of hazard controls 3Health News:Physician bias might keep life-saving transplants from black and Hispanic patients 2Health News:United States Olympic Committee Announces D.I.S.C. Sports and Spine Center as an Official Medical Services Provider 2Health News:United States Olympic Committee Announces D.I.S.C. Sports and Spine Center as an Official Medical Services Provider 3Health News:Surrey College Students Collect Clothing for Women and Children 2
...tworks, Inc. has announced that it has sold the ri...enaming MyBlackBook.Org, the popular sexual histor... New York, NY (PRWEB) February 5, 2...it,s sexual health service to nOOkist™ ( htt...
...president of American Life League, issued a statem...hbishop Raymond Burke, prefect of the Apostolic Si..., (Logo: http://www.newscom.com/cgi-bin/prnh/2008...ve Holy Communion and is not to be given Holy Comm...
... Hospitals of America (PHA) congratulates Congress...de healthcare access and insurance to millions of ...utive Director. "Congress recognized that the SCH...y attached to this important package." , , For th...
...Attorney General Andrew Cuomo and MVP Health Care ...n to establish a new not-for-profit organization t...ment data for use by health insurers who choose to...tate New York based health insurer. The company i...
...t Cigarette Equivalent for First Time , , WASHING...cates a dramatic increase in the use of cigarillos...ng trend given the popularity of these products wi...n increased 240 percent, while cigarillos increase...
...ds, and it affects more youngsters than flu, study...ews) -- It,s called respiratory syncytial virus (R...one of every 13 visits to a pediatrician, and one ...en. And, it,s not just kids with underlying lung ...
Other Medicine News:Health News:Resorb Networks, Inc Sells MyBlackBook Trademarks, Announces Sexual History Tracking Service's New Name, nOOkist™ 2Health News:Resorb Networks, Inc Sells MyBlackBook Trademarks, Announces Sexual History Tracking Service's New Name, nOOkist™ 3Health News:American Life League: Vatican Says Bishops Must Refuse Communion to Pro-Abortion Politicians 2Health News:Physician Hospitals of America (PHA) Congratulates Congress on its Passage of a 'Clean' SCHIP Children's Health Bill 2Health News:MVP Health Care is First Upstate New York Based Health Insurer to Agree with Attorney General Andrew Cuomo on Out-Of-Network Provider Payment Reform 2Health News:Little Cigar Consumption on the Rise, While Cigarette Use Declines 2Health News:Little Cigar Consumption on the Rise, While Cigarette Use Declines 3Health News:Little Cigar Consumption on the Rise, While Cigarette Use Declines 4Health News:RSV to Blame for 1 in 13 Pediatrician Visits 2Health News:RSV to Blame for 1 in 13 Pediatrician Visits 3
(Date:11/9/2009)...ewswire/ -- Bend Research Inc., a company,with mor...ve pharmaceutical,technologies to help clients sol...roblems, announced today that it has entered into ...orated, a global biotechnology company,headquarter...ollaboration, Vertex will utilize Bend,s formulati...
(Date:11/9/2009)...wswire-FirstCall/ -- Clarient, Inc. (Nasdaq: CLRT... pathologists, oncologists and the pharmaceutical ...make presentations at two upcoming investor confer...on will be made at the Lazard Capital Markets Sixt...uesday, November 17. The conference will be held a...
(Date:11/7/2009)...wire/ -- Patients reported C1-esterase inhibitor (...ating acute swelling attacks at any body location ...rding to data presented today at the 2009 American...I) Annual Meeting. The results come from a self-re...th the ongoing, prospective, open label I nternat...
Breaking Medicine Technology:Bend Research and Vertex Pharmaceuticals Enter New Scientific Collaboration 2Bend Research and Vertex Pharmaceuticals Enter New Scientific Collaboration 3Clarient to Present at Upcoming Healthcare Investor Conferences in New York City 2Hereditary Angioedema Patients Report: C1-Esterase Inhibitor Concentrate Effective in Treating Acute Attacks, Helps Them Avoid Emergency Care 2Hereditary Angioedema Patients Report: C1-Esterase Inhibitor Concentrate Effective in Treating Acute Attacks, Helps Them Avoid Emergency Care 3Viral Genetics Completes Second Major Debt Conversion 55463 1Viral Genetics Completes Second Major Debt Conversion 55463 2Viral Genetics Completes Second Major Debt Conversion 55463 3Spokane Washington Man Indicted On Civil Rights Charges Related to Threats to Reproductive Health Services Clinic 55460 1Council for American Medical Innovation Honors Health Champion Senator Edward M Kennedy 55457 1Council for American Medical Innovation Honors Health Champion Senator Edward M Kennedy 55457 2Council for American Medical Innovation Honors Health Champion Senator Edward M Kennedy 55457 3
...le with Diabetes, Hospital,and Professional Charge...URGH, April 02, 2007 /PRNewswire-FirstCall/ -- The...ced today the,release of a new report on the preva...ype 2 diabetes. The inaugural Pittsburgh Type,2 Di...ient,demographics, hospital and professional charg...
...r 3, 2007 - Repros,Therapeutics Inc. (NasdaqGM:RPR... of Proellex(TM), an oral drug being developed to,...uggests that,treatment with Proellex results in a ...mptoms associated with uterine,fibroids and is gen..., This 12 week, double-blind study compared two do...
Other Medicine Technology:State of Diabetes in Pittsburgh: Pittsburgh Business Group on,Health Releases Report 2State of Diabetes in Pittsburgh: Pittsburgh Business Group on,Health Releases Report 3State of Diabetes in Pittsburgh: Pittsburgh Business Group on,Health Releases Report 4Repros' Proellex Shows Statistically Significant Improvement in,Primary Endpoint in Phase 2 Trial in the Treatment of Uterine,Fibroids 2Repros' Proellex Shows Statistically Significant Improvement in,Primary Endpoint in Phase 2 Trial in the Treatment of Uterine,Fibroids 3Repros' Proellex Shows Statistically Significant Improvement in,Primary Endpoint in Phase 2 Trial in the Treatment of Uterine,Fibroids 4Repros' Proellex Shows Statistically Significant Improvement in,Primary Endpoint in Phase 2 Trial in the Treatment of Uterine,Fibroids 5
...ies is a national reference laboratory and a world...development. ARUP offers an extensive test menu of...al and anatomic pathology. Owned by the University...than half of the nation's university teaching hosp...
...ies is a national reference laboratory and a world...development. ARUP offers an extensive test menu of...al and anatomic pathology. Owned by the University...than half of the nation's university teaching hosp...
...ies is a national reference laboratory and a world...development. ARUP offers an extensive test menu of...al and anatomic pathology. Owned by the University...than half of the nation's university teaching hosp...
...ies is a national reference laboratory and a world...development. ARUP offers an extensive test menu of...al and anatomic pathology. Owned by the University...than half of the nation's university teaching hosp...
Medicine Products: